We Think Almirall (BME:ALM) Can Stay On Top Of Its Debt
Jan 04
Spanish (IBEX) Pharma Industry Analysis
UpdatedJan 28, 2023
DataAggregated Company Financials
Companies5
- 7D3.3%
- 3M-8.2%
- 1Y-25.0%
- YTD2.5%
The Pharma industry is up 2.2% in the last week, with Laboratorios Farmaceuticos Rovi up 5.1%. However, the industry is down 26% over the past year. As for the next few years, earnings are expected to grow by 15% per annum.
Industry Valuation and Performance
Has the Spanish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 28 Jan 2023 | €5.0b | €2.3b | €275.8m | 29.7x | 18.3x | 2.2x |
| Mon, 26 Dec 2022 | €4.8b | €2.3b | €275.8m | 27.4x | 17.6x | 2.1x |
| Wed, 23 Nov 2022 | €5.2b | €2.3b | €276.7m | 27.6x | 18.9x | 2.2x |
| Fri, 21 Oct 2022 | €5.4b | €2.3b | €306.3m | 22.3x | 17.5x | 2.3x |
| Sun, 18 Sep 2022 | €5.6b | €2.3b | €306.3m | 25.7x | 18.3x | 2.4x |
| Tue, 16 Aug 2022 | €6.0b | €2.3b | €306.3m | 28.7x | 19.6x | 2.6x |
| Thu, 14 Jul 2022 | €6.8b | €2.3b | €225.4m | 18x | 30.1x | 3x |
| Sat, 11 Jun 2022 | €6.4b | €2.3b | €225.4m | 17.1x | 28.3x | 2.8x |
| Mon, 09 May 2022 | €6.9b | €2.2b | €200.5m | 22.5x | 34.6x | 3.2x |
| Wed, 06 Apr 2022 | €7.4b | €2.1b | €200.5m | 24.9x | 36.8x | 3.4x |
| Fri, 04 Mar 2022 | €7.1b | €2.1b | €200.5m | 25.3x | 35.5x | 3.3x |
| Sun, 30 Jan 2022 | €6.8b | €2.0b | €177.1m | 31.2x | 38.7x | 3.3x |
| Tue, 28 Dec 2021 | €7.3b | €2.0b | €177.1m | 36x | 41.2x | 3.6x |
| Thu, 25 Nov 2021 | €6.6b | €2.0b | €157.7m | 41.6x | 42x | 3.3x |
| Sat, 23 Oct 2021 | €7.0b | €2.0b | €151.3m | 40.8x | 46.2x | 3.6x |
| Mon, 20 Sep 2021 | €7.1b | €2.0b | €151.3m | 38.9x | 46.9x | 3.6x |
| Wed, 18 Aug 2021 | €7.6b | €2.0b | €151.3m | 43.7x | 50.3x | 3.9x |
| Wed, 02 Jun 2021 | €7.1b | €1.9b | €205.9m | 44.8x | 34.3x | 3.8x |
| Sat, 06 Mar 2021 | €6.0b | €1.9b | €213.8m | 33.8x | 28.1x | 3.2x |
| Tue, 08 Dec 2020 | €5.5b | €1.9b | €198.7m | 34.2x | 27.8x | 2.9x |
| Mon, 31 Aug 2020 | €4.4b | €1.9b | €217.7m | 24.1x | 20.3x | 2.3x |
| Thu, 04 Jun 2020 | €4.6b | €2.0b | €241.9m | 22.3x | 19x | 2.4x |
| Sun, 08 Mar 2020 | €4.8b | €1.9b | €214.1m | 26.9x | 22.4x | 2.6x |
Price to Earnings Ratio
24.7x
Current Industry PE
- Investors are pessimistic on the Spanish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 18.1x which is lower than its 3-year average PE of 28.9x.
- The 3-year average PS ratio of 2.9x is higher than the industry's current PS ratio of 2.1x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 8.8% per year over the last three years.
- Revenues for these companies have grown 7.6% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Spanish Pharma compare with similar industries?
| ES Market | 1.56% | |
| Healthcare | 2.50% | |
| Pharma | 3.25% | |
| Pharma | 3.25% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ROVI Laboratorios Farmaceuticos Rovi | €39.80 | 7.9% +€154.8m | -36.8% | PE12.1x | |
| ALM Almirall | €9.12 | 0.9% +€15.4m | -20.4% | PE175.3x | |
| RJF Laboratorio Reig Jofre | €2.59 | 4.9% +€9.3m | -9.8% | PE47.2x |